[LONDON, UK – May 9th, 2025] – The bovine vaccines market is set for explosive growth, driven by mRNA breakthroughs and zoonotic disease emergencies. According to a 300-page report by ClearView Market Insights, the sector will expand at an 8.9% CAGR, reaching $3.4 billion by 2030.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-bovine-vaccines-market/
Key Industry Shifts
- mRNA Vaccine Dominance
- Pfizer’s BOVILIS® FMD Vaccine: Cuts outbreaks by 95% in Indian trials.
- Zoetis’s BRD Vaccine: Reduces feedlot deaths by 40%, saving $50M annually in U.S. alone.
- Disease Outbreak Response
- India’s LSD Crisis: Government orders 200M doses of Hester’s heat-stable vaccine.
- Africa’s FMD Surge: AU partners with Boehringer for 1B doses by 2027.
- Policy & Funding Surge
- EU’s $500M “One Health” Fund: Accelerates livestock vaccine R&D.
- USDA’s “Outbreak Preparedness” Program: Stocks mRNA vaccines for emergent strains.
Quotes from Industry Leaders
- Dr. James Fowler, Pfizer Animal Health:
"mRNA isn’t just for humans—it’s transforming cattle health. Our FMD vaccine could eradicate the disease by 2040." - Dr. Priya Agarwal, Hester Biosciences:
"Heat-stable vaccines are a game-changer for rural Africa. No cold chain means no wasted doses."
Farmer & Economic Impact
- Dairy Farms: Vaccinated herds show 12% higher milk yields (FAO data).
- Export Markets: Brazil’s FMD-free status boosts beef exports by $2B/year.
Future Projections
- 2026: Self-amplifying mRNA vaccines enter trials.
- 2028: Needle-free nasal vaccines capture 20% market share.
About ClearView Market Insights
ClearView Market Insights is a globally recognized research firm specializing in industrial automation, logistics, and smart manufacturing. Our reports provide data-driven insights to help businesses navigate evolving markets.
For more insights, visit https://clearviewmarketinsights.com/
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
